Epigenomics AG

EANS-Voting Rights: Epigenomics AG
Release of a voting rights announcement according to article 26, section 1.1 WpHG (Securities Trading Act) with the aim of a Europe-wide distribution

--------------------------------------------------------------------------------
  Notification of voting rights transmitted by euro adhoc. The issuer is
  responsible for the content of this announcement.
-------------------------------------------------------------------------------- 
Person/company obliged to make the notification: 
----------------------------------- 
Name:    Federated Equity Management Company of Pennsylvania
Place:   Pittsburgh, PA
State:   USA 
Company data:
----------------------- 
Name:    Epigenomics AG
Address: Kleine Präsidentenstraße 1, 10178 Berlin
Place:   Berlin
State:   Deutschland 
Voting Rights: Release of a Voting Rights Notification (§§ 21 et seq. WpHG) in
Accordance with § 26, para. 1 WpHG (German Securities Trading Act) with the Aim
of an Europe-wide Distribution 
Issuer: 
Epigenomics AG
Kleine Präsidentenstr. 1
10178 Berlin
Germany 
Voting Rights Notification: 
On 06 April 2010 Federated Investors Inc., Pittsburgh, PA, USA, notified
Epigenomics AG in the name and on behalf of Federated Equity Management Company
of Pennsylvania, Pittsburgh, PA, USA, on the holding of voting rights held in
Epigenomics AG pursuant to § 21 para. 1 WpHG in connection with § 22 para. 1
sent. 1 no. 6 WpHG: 
On 30 March 2010 the voting rights in Epigenomics AG held by Federated Equity
Management Company of Pennsylvania fell below the 10 per cent threshold of § 21
para. 1 WpHG and Federated Equity Management Company of Pennsylvania held at
this date 7.55 per cent of the voting rights (i.e. 2,219,690 voting rights of
the 29,394,724 shares outstanding at that date) in Epigenomics AG. 
All 7.55 per cent of the voting rights (2,219,690 voting rights) are attributed
to Federated Equity Management Company of Pennsylvania pursuant to § 22 para. 1
sent. 1 no. 6 WpHG. Some of the voting rights are attributed to Federated Equity
Management Company of  Pennsylvania by Federated Kaufmann Fund, Pittsburgh, PA,
USA, which holds directly 3 or more per cent of the voting rights in Epigenomics
AG. 
Date of release: 07 April 2010 
Epigenomics AG
The Executive Board 
Contact: 
Epigenomics AG
Dr. Achim Plum
Senior Vice President Corporate Development
Tel.: +49 (0)30 24345 368
Fax: +49 (0)30 24345 555
Email: achim.plum@epigenomics.com 
end of announcement                               euro adhoc
-------------------------------------------------------------------------------- 

Further inquiry note:


Branche: Biotechnology
ISIN: DE000A0BVT96
WKN: A0BVT9
Index: Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / free trade

Original-Content von: Epigenomics AG, übermittelt durch news aktuell

Weitere Meldungen: Epigenomics AG

Das könnte Sie auch interessieren: